Ionis Pharmaceuticals (IONS) EBITDA (2009 - 2026)
Ionis Pharmaceuticals (IONS) EBITDA from Jun 30, 2009 to Mar 31, 2026. The TTM Ionis Pharmaceuticals (IONS) EBITDA is -$341M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Ionis Pharmaceuticals (IONS) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -26.34% |
| 3 Years TTM | -9.06% |
| 5 Years TTM | +12.55% |
| 10 Years TTM | +15.67% |
| All Time TTM | +15.35% |
Annual EBITDA change of Ionis Pharmaceuticals (IONS)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$114M | -69.30% |
| 2025 | -$372M | -20.15% |
| 2024 | -$465M | +35.53% |
| 2023 | -$343M | -13.24% |
| 2022 | -$396M | +2592.93% |
| 2021 | -$15M | -90.74% |
| 2020 | -$159M | -141.94% |
| 2019 | $378M | -846.83% |
| 2018 | -$51M | -234.19% |
| 2017 | $38M | -397.79% |
| 2016 | -$13M | -81.56% |
| 2015 | -$69M | +66.34% |
| 2014 | -$41M | -8.25% |
| 2013 | -$45M | -27.13% |
| 2012 | -$62M | -4.12% |
| 2011 | -$65M | +48.23% |
| 2010 | -$44M | +84.41% |
| 2009 | -$24M | +131.60% |
| 2008 | -$10M | N/A |
Comparison Ionis Pharmaceuticals (IONS) five years EBITDA CAGR with competitors
Ionis Pharmaceuticals (IONS) five years EBITDA CAGR is 12.55%.